Nebivolol Glenmark Arzneimittel (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Glenmark Arzneimittel, is a beta‑adrenergic blocker presented as a tablet for oral use. It is prescribed to lower elevated blood pressure in adult patients with hypertension. The medication works by selectively blocking β1‑adrenergic receptors and enhancing nitric oxide release, which contributes to vasodilation and reduced peripheral resistance.

GNH USA supplies Nebivolol Glenmark Arzneimittel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to healthcare providers across multiple regions.

Nebivolol is a selective β1‑adrenergic blocker used primarily in the management of high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk in adult patients.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: often related to blood pressure lowering. - Fatigue: general tiredness or lack of energy. - Bradycardia: slower than normal heart rate. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Hypotension: significant drop in blood pressure causing faintness. - Bronchospasm: airway constriction, especially in patients with asthma. - Allergic reactions: rash, itching, or swelling. - Hepatic enzyme elevation: abnormal liver function tests.

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor for potential risks. - Blood pressure monitoring: ensure adequate control and avoid excessive lowering. - Cardiac assessment: evaluate heart rate and rhythm, especially in patients with conduction disorders. - Asthma or COPD: use with caution due to possible bronchospasm. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Renal impairment: dose adjustment may be required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Other beta‑blockers: additive cardiac depression. - Calcium channel blockers (verapamil, diltiazem): increased risk of bradycardia and AV block. - Potent CYP2D6 inhibitors (paroxetine, fluoxetine): elevated nebivolol plasma levels. - Combined antihypertensives (ACE inhibitors, ARBs): may cause excessive hypotension.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect. - Diuretics: risk of electrolyte imbalance and hypotension. - Antidiabetic agents: potential alteration of glucose control. - Other antiarrhythmics: possible additive effects on cardiac conduction. - Alcohol: may enhance dizziness and hypotensive response.